Evidence map›Paper›PMID 33594523›Full record

ArticleMikrochimica acta2021

Randomly positioned gold nanoparticles as fluorescence enhancers in apta-immunosensor for malaria test.

Antonio Minopoli, Bartolomeo Della Ventura, Raffaele Campanile, Julian A Tanner, Andreas Offenhäusser, Dirk Mayer, Raffaele Velotta

Open access · hybridAbstract read
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Antonio MinopoliInstitute of Biological Information Processing (IBI-3), Bioelectronics, Forschungszentrum Jülich, 52425, Jülich, Germany.
Bartolomeo Della VenturaDepartment of Physics "E. Pancini", University of Naples "Federico II", Via Cintia 26, 80126, Naples, Italy.
Raffaele CampanileDepartment of Physics "E. Pancini", University of Naples "Federico II", Via Cintia 26, 80126, Naples, Italy.
Julian A TannerSchool of Biomedical Sciences, University of Hong Kong, Hong Kong, SAR, China.
Andreas OffenhäusserInstitute of Biological Information Processing (IBI-3), Bioelectronics, Forschungszentrum Jülich, 52425, Jülich, Germany.
Dirk MayerInstitute of Biological Information Processing (IBI-3), Bioelectronics, Forschungszentrum Jülich, 52425, Jülich, Germany. dirk.mayer@fz-juelich.de.
Raffaele VelottaDepartment of Physics "E. Pancini", University of Naples "Federico II", Via Cintia 26, 80126, Naples, Italy. rvelotta@unina.it.ORCID 0000-0003-1077-8353
Forschungszentrum Jülich · DEUniversity of Naples Federico II · ITUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A plasmon-enhanced fluorescence-based antibody-aptamer biosensor - consisting of gold nanoparticles randomly immobilized onto a glass substrate via electrostatic self-assembly - is described for specific detection of proteins in whole blood. Analyte recognition is realized through a sandwich scheme with a capture bioreceptor layer of antibodies - covalently immobilized onto the gold nanoparticle surface in upright orientation and close-packed configuration by photochemical immobilization technique (PIT) - and a top bioreceptor layer of fluorescently labelled aptamers. Such a sandwich configuration warrants not only extremely high specificity, but also an ideal fluorophore-nanostructure distance (approximately 10-15 nm) for achieving strong fluorescence amplification. For a specific application, we tested the biosensor performance in a case study for the detection of malaria-related marker Plasmodium falciparum lactate dehydrogenase (PfLDH). The proposed biosensor can specifically detect PfLDH in spiked whole blood down to 10 pM (0.3 ng/mL) without any sample pretreatment. The combination of simple and scalable fabrication, potentially high-throughput analysis, and excellent sensing performance provides a new approach to biosensing with significant advantages compared to conventional fluorescence immunoassays.

Indexed as

Antibodies, ImmobilizedAptamers, NucleotideBiosensing TechniquesFluorescent DyesGoldHumansImmunoassayLimit of DetectionL-Lactate DehydrogenaseMalariaMetal NanoparticlesPlasmodium falciparumProtozoan ProteinsAntibodies, ImmobilizedAptamers, NucleotideFluorescent DyesGoldL-Lactate DehydrogenaseProtozoan ProteinsAntibody-aptamer biosensorGold nanoparticle arrayMalaria markerNanoplasmonicsPhotochemical immobilization techniquePlasmon-enhanced fluorescence

Identifiers

PMID33594523
PMCPMC7886758
OpenAlexW3129225895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.